International Business News - Mylan http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Generic drug maker Mylan Inc. said Thursday it received tentative approval from the Food and Drug Administration to market its 600 milligram linezolid tablets. http://www.ibtimes.com/articles/20080703/mylan-gets-fda-ok-to-market-generic-antibiotic.htm Thu, 03 Jul 2008 08:06:53 EDT Drug developer Mylan Inc. said Monday the Food and Drug Administration granted tentative approval for the generic version of Sanofi Aventis' hypertension drug Avalide. http://www.ibtimes.com/articles/20080616/mylan-gets-final-fda-ok-for-generic-antidepressant.htm Mon, 16 Jun 2008 15:16:41 EDT Generic drug company Mylan Inc. is cutting jobs at a plant in central Puerto Rico. City of Caguas spokesman Carlos Rosario said Wednesday that 100 jobs will be eliminated in coming weeks. The company has declined to specify the number of layoffs. http://www.ibtimes.com/articles/20080611/mylan-to-cut-100-jobs-in-puerto-rico.htm Wed, 11 Jun 2008 15:10:53 EDT Drug developer Mylan Inc. said Tuesday an appeals court affirmed an earlier ruling stating that its generic version of heartburn drug Prilosec does not infringe on AstraZeneca's patent. http://www.ibtimes.com/articles/20080610/mylan-claims-win-in-patent-dispute-appeal.htm Tue, 10 Jun 2008 15:50:31 EDT Shares of Teva Pharmaceutical Industries Ltd. fell Tuesday after its blockbuster multiple sclerosis drug Copaxone faced the possibility of a generic rival from competitor Mylan Inc. http://www.ibtimes.com/articles/20080610/generic-copaxone-deal-boosts-mylan-sinks-teva.htm Tue, 10 Jun 2008 17:14:27 EDT Drug developer Mylan Inc. said Tuesday it signed a deal for worldwide marketing and distribution rights to a generic version of Teva Pharmaceutical Industries Ltd's blockbuster multiple sclerosis injection Copaxone. http://www.ibtimes.com/articles/20080610/mylan-gains-rights-to-generic-version-of-teva-drug.htm Tue, 10 Jun 2008 10:20:14 EDT Mylan Inc. said Monday the Food and Drug Administration approved the company's application to sell generic capsules of Sonata, an insomnia treatment. The company will immediately begin shipping Zaleplon capsules in 5 and 10 mg doses. http://www.ibtimes.com/articles/20080609/mylan-gets-fda-approval-to-market-generic-sonata.htm Mon, 09 Jun 2008 12:46:50 EDT Generic drug developer Mylan Inc. said Thursday that a subsidiary has entered into a settlement and license agreement with Abbott Laboratories relating to a generic version of Abbott's anti-seizure drug Depakote ER. http://www.ibtimes.com/articles/20080605/mylan-abbott-settle-anti-seizure-drug-dispute.htm Thu, 05 Jun 2008 13:06:09 EDT Generic drug maker Mylan Inc. said Wednesday it is being sued by Japanese drug maker Daiichi Sankyo for patent infringement on blood pressure drug Azor. http://www.ibtimes.com/articles/20080604/mylan-sued-for-patent-infringement-on-drug-azor.htm Wed, 04 Jun 2008 09:20:35 EDT Generic and specialty pharmaceutical company Mylan Inc. said Monday it has acquired the central eastern European generics businesses of German drug maker Merck KGaA, as part of an agreement signed last year. http://www.ibtimes.com/articles/20080602/mylan-acquires-eastern-european-merck-kgaa-units.htm Mon, 02 Jun 2008 08:05:21 EDT Shares of Mylan Inc. fell Friday after the generic drug developer cut its profit guidance spanning the next several years, though Wall Street expects the company to meet the new targets. http://www.ibtimes.com/articles/20080509/mylan-shares-dip-as-the-company-cuts-profit-guidance.htm Fri, 09 May 2008 17:12:16 EDT Among the stock activity stories for Friday, May 9, from AP Financial News: NEW YORK (AP) _ Shares of Mylan Inc. fell Friday after the generic drug developer cut its profit guidance spanning the next several years, though Wall Street expects the company to meet the new targets. http://www.ibtimes.com/articles/20080509/movers-roundup-mylan-assured-guaranty.htm Fri, 09 May 2008 16:08:12 EDT Generic drug maker Mylan Inc. Thursday said its first-quarter loss widened due to a $385 million noncash goodwill impairment charge related to its specialty business, though adjusted results beat analyst expectations. http://www.ibtimes.com/articles/20080508/mylan-1q-loss-widens-on-impairment-charge-shares-fall.htm Thu, 08 May 2008 17:42:11 EDT Drug developer Mylan Inc. said Monday it received Food and Drug Administration approval for generic versions of AstraZeneca's hypertension treament, Plendil extended-release tablets. http://www.ibtimes.com/articles/20080421/mylan-gets-fda-approval-for-generic-hypertension-drug.htm Mon, 21 Apr 2008 15:07:10 EDT Mylan Laboratories Inc. Chief Executive Robert J. Coury received compensation for a special nine-month transitional year totaling $10.3 million, according to the drug developer's proxy statement filed Monday. http://www.ibtimes.com/articles/20080331/mylan-ceo-gets-10-3-million.htm Mon, 31 Mar 2008 10:48:44 EDT A special counsel for drug developer Mylan Inc. company bought 10,000 shares of stock, according to a Securities and Exchange Commission filing Monday. http://www.ibtimes.com/articles/20080311/mylan-counsel-buys-shares.htm Tue, 11 Mar 2008 15:25:24 EDT The chief executive and vice chairman of drug developer Mylan Inc. bought 20,000 shares of stock, according to a Securities and Exchange Commission filing Friday. http://www.ibtimes.com/articles/20080310/mylan-ceo-robert-coury-buys-shares.htm Mon, 10 Mar 2008 12:51:18 EDT The chief executive of drug developer Mylan Inc. bought 15,000 shares of common stock, according to a Securities and Exchange Commission filing Wednesday. http://www.ibtimes.com/articles/20080306/mylan-ceo-buys-15-000-shares.htm Thu, 06 Mar 2008 13:18:21 EST Shares of generic drug developer Mylan Inc. fell to their lowest point in nearly six years on lingering concerns over the company's plan to sell its Dey LP unit. http://www.ibtimes.com/articles/20080303/mylan-shares-hit-new-low-on-outlook.htm Mon, 03 Mar 2008 18:30:11 EST Generic drug maker Mylan Inc. said Friday a Florida judge will allow the company to sell a generic version of Abbott Laboratories' thyroid medication Synthroid. http://www.ibtimes.com/articles/20080208/mylan-gets-ok-to-sell-thyroid-drug.htm Fri, 08 Feb 2008 10:56:19 EST